Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CNSI Cambridge Neuroscience -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (592)	5/28/2000 2:25:00 PM
From: Mike McFarland	Respond to of 675

It might be nice if we got swapped into our CEN.L as biotech bottoms out--with this market sell off and all-techs-must-go CeNeS is also down here in penny, er, pence land at 80x85p. (uh, let's just call it CeNeS CNS for short on the thread--much faster to type) After the merge, three in phase II: recap.com cenes.com recap.com (again, 5161 is not yet showing phase II, supposed to be this year) CNS quote uk.finance.yahoo.com I'm as disappointed as anybody that cnsi is going out at 2 1/4, and especially that it is trading down here at 1 1/2--which is pretty close to my cost. But there are positives--less management drawing six figures, and all that merger synergy sorta thing. I can live with it if I have to.